Literature DB >> 15233557

Ectopic secretion of LH by an endocrine pancreatic tumor.

E Brignardello1, R Manti, M Papotti, E Allìa, D Campra, G Isolato, M C Cassinis, G Fronda, G Boccuzzi.   

Abstract

Ectopic production of biologically active glycoprotein hormones other than hCG has been reported in exceptional cases. A 61-yr-old man came to our Unit complaining of weakness, fatigue and reduced libido with erectile dysfunction. There was also a history of polycythemia, known for about 10 yr and never further investigated. The physical examination showed acne and redness of facial skin and upper chest; no other significant abnormalities were detected. Serum levels of LH were very high, whereas alpha-subunit and hCG were only slightly increased. Testosterone and 17beta-estradiol levels were increased too. Abdominal computed tomography (CT) scan revealed a large hypervascularized mass within the pancreatic tail, which was surgically removed by distal splenopancreatectomy. Diffuse immunoreactivity for LH was detected in more than 70% of the tumor cells. The alpha-subunit was also positive, while chorionic gonadotropin had only a focal reactivity. Reverse transcriptase-polymerase chain reaction (RT-PCR) and Southern Blot analysis confirmed the synthesis of LH by the tumor. Four weeks after surgery, serum levels of LH, alpha-subunit, testosterone, hCG and 17beta-estradiol were all undetectable. The redness of facial skin and upper chest had disappeared, but libido was still reduced. At a further control, 3 months after surgery, serum levels of LH, FSH, hCG, alpha-subunit and 17beta-estradiol were all within the normal range, as well as hemoglobin concentration and the red blood cells count. Testosterone was slightly below normal, but the patient reported an increase of libido. This is an unusual case of ectopic secretion of LH from an endocrine tumor of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233557     DOI: 10.1007/BF03351063

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

1.  Androgen-induced erythrocytosis: is it erythropoietin?

Authors:  R D Dickerman; R Pertusi; J Miller; N Y Zachariah
Journal:  Am J Hematol       Date:  1999-06       Impact factor: 10.047

2.  Polycythaemia as a complication of transdermal testosterone therapy.

Authors:  J F Viallard; G Marit; P Mercié; B Leng; J Reiffers; J L Pellegrin
Journal:  Br J Haematol       Date:  2000-07       Impact factor: 6.998

Review 3.  State of the art and future prospects in the management of neuroendocrine tumors.

Authors:  K Oberg
Journal:  Q J Nucl Med       Date:  2000-03

4.  Ectopic luteinizing hormone secretion and anovulation.

Authors:  Boaz Hirshberg; P Michael Conn; Gabriel I Uwaifo; Keith L Blauer; Bradly D Clark; Lynnette K Nieman
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

5.  Androgen-induced erythrocytosis.

Authors:  R D Dickerman; R Pertusi; N Y Zachariah; F Schaller
Journal:  Am J Hematol       Date:  1998-11       Impact factor: 10.047

6.  Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty.

Authors:  E W Leschek; W Y Chan; D A Diamond; M Kaefer; J Jones; K M Barnes; G B Cutler
Journal:  J Pediatr       Date:  2001-06       Impact factor: 4.406

7.  Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy.

Authors:  M Papotti; S Croce; M Bellò; M Bongiovanni; E Allìa; M Schindler; G Bussolati
Journal:  Virchows Arch       Date:  2001-12       Impact factor: 4.064

8.  Hepatocellular carcinoma: an unusual course with hyperthyroidism and inappropriate thyroid-stimulating hormone production.

Authors:  J H Helzberg; M S McPhee; E J Zarling; B P Lukert
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

9.  Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).

Authors:  S Dirnhofer; M Freund; H Rogatsch; S Krabichler; P Berger
Journal:  Hum Pathol       Date:  2000-08       Impact factor: 3.466

10.  Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.

Authors:  L Katznelson; J M Alexander; H A Bikkal; J L Jameson; D W Hsu; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1992-06       Impact factor: 5.958

View more
  4 in total

1.  Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example.

Authors:  Taichi Nakamura; Hisato Igarashi; Tetsuhide Ito; Robert T Jensen
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

Review 2.  Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.

Authors:  Guido Rindi; Ozgur Mete; Silvia Uccella; Olca Basturk; Stefano La Rosa; Lodewijk A A Brosens; Shereen Ezzat; Wouter W de Herder; David S Klimstra; Mauro Papotti; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2022-03-16       Impact factor: 3.943

Review 3.  Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-12       Impact factor: 3.043

Review 4.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.

Authors:  David C Metz; Robert T Jensen
Journal:  Gastroenterology       Date:  2008-08-12       Impact factor: 22.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.